Document is current
Any future updates will be listed below
-
Authors
Paik, Donggi https://orcid.org/0000-0003-1031-0371
Yao, Lina https://orcid.org/0000-0003-1018-5646
Zhang, Yancong https://orcid.org/0000-0002-2768-2975
Bae, Sena
D’Agostino, Gabriel D.
Zhang, Minghao
Kim, Eunha https://orcid.org/0000-0001-7041-1727
Franzosa, Eric A. https://orcid.org/0000-0002-8798-7068
Avila-Pacheco, Julian https://orcid.org/0000-0001-9388-3946
Bisanz, Jordan E. https://orcid.org/0000-0002-8649-1706
Rakowski, Christopher K.
Vlamakis, Hera https://orcid.org/0000-0003-1086-9191
Xavier, Ramnik J. https://orcid.org/0000-0002-5630-5167
Turnbaugh, Peter J. https://orcid.org/0000-0002-0888-2875
Longman, Randy S.
Krout, Michael R.
Clish, Clary B. https://orcid.org/0000-0001-8259-9245
Rastinejad, Fraydoon
Huttenhower, Curtis https://orcid.org/0000-0002-1110-0096
Huh, Jun R. https://orcid.org/0000-0002-1540-6244
Devlin, A. Sloan https://orcid.org/0000-0001-5598-3751
- License Information
-
More Information
Article History
Received: 4 December 2020
Accepted: 27 January 2022
First Online: 16 March 2022
Competing interests
: A.S.D. is a consultant for Takeda Pharmaceuticals and Axial Therapeutics. J.R.H. is a consultant for CJ Research Center and Interon Laboratories and on the scientific advisory board for ChunLab. P.J.T. is on the scientific advisory board for Kaleido, Pendulum, Seres and SNIPRbiome. C.H. is on the scientific advisory boards of Seres Therapeutics, Empress Therapeutics, and ZOE Nutrition.
